Physician profile
Anthony Haney
NPI 1760415590
$7,396.87
in general payments reported to CMS, 2019-2025
36 companies · $959 in 2025
The $959 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,063 · 2020: $606 · 2021: $510 · 2022: $1,620 · 2023: $1,429 · 2024: $1,211 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,566 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,566.22 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,216.87 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,059.36 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $681.37 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $490.10 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $432.24 | 2019-2023 | Xarelto |
| Abiomed | $408.17 | 2022-2025 | Impella |
| Amgen INC. | $384.34 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $318.22 | 2022-2024 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $299.38 | 2019-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $226.02 | 2022-2025 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals Lp | $212.36 | 2019-2023 | Farxiga, Brilinta, Wainua |
| Novo Nordisk INC | $201.37 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $187.81 | 2019-2025 | Onpattro |
| Philips North America LLC | $183.64 | 2022-2024 | (Ck4) Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $171.51 | 2021-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $127.44 | 2021-2024 | Nexletol |
| United Therapeutics Corporation | $106.06 | 2019-2024 | Tyvaso |
| Lexicon Pharmaceuticals, INC. | $87.59 | 2023-2024 | Inpefa |
| Lantheus Medical Imaging, INC. | $81.22 | 2022-2025 | |
| Boston Scientific Corporation | $70.66 | 2025 | Eluvia, Watchman Flx |
| Irhythm Technologies, INC. | $61.77 | 2022-2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $61.09 | 2019-2021 | |
| Abbott Laboratories | $50.30 | 2019-2025 | Triclip |
| Nuwellis, INC. | $36.10 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.49 | 2023 | Opsumit |
| Arbor Pharmaceuticals, INC. | $24.52 | 2019 | |
| Terumo Medical Corporation | $23.82 | 2025 | Navicross |
| Kestra Medical Technology Services, INC. | $23.10 | 2025 | Assure Wcd |
| Lundbeck LLC | $22.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.88 | 2019 | |
| Daiichi Sankyo INC. | $18.99 | 2023 | Injectafer |
| Astellas Pharma US INC | $17.53 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $15.95 | 2023 | Arcalyst |
| Surmodics, INC. | $15.86 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Baxter Healthcare | $13.94 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Haney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.